Prof. Dr. Yuri Gleba, CEO of Nomad Bioscience gave the interview to Transkript: Wirtschaft, Technologie, Leben magazine

Wirtschaft, Technologie, Leben magazine

Related articles

Nomad Bioscience GmbH Expands Customer-Tailored Services for Recombinant Protein Production

Nomad Bioscience GmbH Expands Customer-Tailored Services for Recombinant Protein Production We are pleased to announce that Nomad Bioscience GmbH is…

NOMAD Bioscience Extends Agreements with Plant Biomass Producers in Extremadura Spain

NOMAD Bioscience Extends Agreements with Plant Biomass Producers in Extremadura Spain Munich, June, 2023 – NOMAD BIOSCIENCE GmbH, Munich, Germany…

Nomad Bioscience and Fraunhofer Institute of Cell Therapy and Immunology Extend their Research and Development Agreement

Nomad Bioscience and Fraunhofer Institute of Cell Therapy and Immunology Extend their Research and Development Agreement Nomad Bioscience GmbH, Munich,…

NOMAD Bioscience receives patents in Japan and Australia for its antibacterials Salmocins

NOMAD Bioscience receives patents in Japan and Australia for its antibacterials Salmocins Munich, October 2022 – NOMAD Bioscience GmbH has…